Ragosa Mark sold KNSA
March 9, 2026 · Form 4 insider transaction
Ragosa Mark sold 17,981 shares of Kiniksa Pharmaceuticals International, plc at $45.58 per share, a transaction worth $819.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
17,981
Price
$45.58
Total value
$819.6K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after30,827
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $44.885 and $45.88. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.